In this paper, we consider the role of willingness to pay (WTP) as a method
for measuring the impact of healthcare programmes on population well-being
. Alternative methods of outcome valuation, such as quality-adjusted life-y
ears (QALYs), measure values through individuals' willingness to trade off
a particular commodity, future life. Moreover, the method of valuation fail
s to incorporate several dimensions of benefit relevant to measuring well-b
eing that are particularly important in programmes aimed at the prevention
and control of influenza. In contrast, WTP provides a broad method of valua
tion based on individuals' willingness to trade off a much wider range of c
ommodities. In addition, WTP incorporates externalities and uncertainty wit
hin individual valuations. We show that the main limitations of the WTP app
roach are not avoided by adoption of the QALY approach.